Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 7, 2012; 18(17): 2043-2052
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2043
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2043
Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication
Ye Zhang, Zhi Du, Third Central Clinical College of Tianjin Medical University, Tianjin 300170, China
Ye Zhang, Zhi Du, Tong Bai, Yi-Jun Wang, Cheng Lou, Feng-Mei Wang, Yu Bai, The Third Central Hospital of Tianjin, Tianjin 300170, China
Bin Yang, Ying-Tang Gao, Tianjin Key Laboratory of Artificial Cell, Tianjin 300170, China
Author contributions: Zhang Y performed the experiments and wrote the manuscript; Yang B, Bai T and Gao YT provided vital reagents and were involved in editing the manuscript; Wang YJ, Lou C, Wang FM and Bai Y collected all the human materials; Du Z designed the study and revised the manuscript.
Supported by Tianjin Health Bureau for research projects, No. 09KY04, No. 2010KZ17 and No. 11KG112
Correspondence to: Zhi Du, Professor of Medicine, The Third Central Hospital of Tianjin, Tianjin 300170, China. zhi-du@163.com
Telephone: +86-22-84112148 Fax: +86-22-24315132
Received: September 30, 2011
Revised: November 25, 2011
Accepted: February 27, 2012
Published online: May 7, 2012
Revised: November 25, 2011
Accepted: February 27, 2012
Published online: May 7, 2012
Core Tip